|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Kidney Stone | |||||
| Unexplained Haematuria | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hematuria | |||||
| Kidney Calculi | |||||
| 3 | More general conditions related to this trial | ||||
| Calculi | |||||
| Hemorrhage | |||||
| Kidney Diseases | |||||
| Nephrolithiasis | |||||
| Pathologic Processes | |||||
| Pathological Conditions, Anatomical | |||||
| Urinary Calculi | |||||
| Urination Disorders | |||||
| Urolithiasis | |||||
| Urologic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Isoproterenol | |||||
| 5 | More general drug interventions related to this trial | ||||
| Adrenergic Agents | |||||
| Adrenergic Agonists | |||||
| Adrenergic beta-Agonists | |||||
| Anti-Asthmatic Agents | |||||
| Autonomic Agents | |||||
| Bronchodilator Agents | |||||
| Cardiotonic Agents | |||||
| Cardiovascular Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Respiratory System Agents | |||||
| Sympathomimetics | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Fredericia Hosptial | |||||